29 years of historical data (1997–2025) · Technology · Software - Infrastructure
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Amdocs Limited trades at 10.2x earnings, 42% below its 5-year average of 17.6x, sitting at the 0th percentile of its historical range. Compared to the Technology sector median P/E of 29.0x, the stock trades at a discount of 65%. On a free-cash-flow basis, the stock trades at 8.6x P/FCF, 44% below the 5-year average of 15.3x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $5.5B | $9.2B | $10.0B | $10.0B | $9.7B | $9.7B | $7.6B | $9.1B | $9.5B | $9.5B | $8.7B |
| Enterprise Value | $6.0B | $9.7B | $10.4B | $10.3B | $9.9B | $9.9B | $7.7B | $8.6B | $9.1B | $8.8B | $8.2B |
| P/E Ratio → | 10.19 | 16.25 | 20.58 | 18.82 | 17.89 | 14.23 | 15.47 | 19.05 | 26.71 | 21.73 | 21.35 |
| P/S Ratio | 1.22 | 2.02 | 1.99 | 2.05 | 2.12 | 2.26 | 1.83 | 2.22 | 2.39 | 2.45 | 2.35 |
| P/B Ratio | 1.66 | 2.64 | 2.85 | 2.81 | 2.72 | 2.67 | 2.09 | 2.56 | 2.72 | 2.65 | 2.53 |
| P/FCF | 8.58 | 14.21 | 16.11 | 14.34 | 18.29 | 13.54 | 16.90 | 17.16 | 29.08 | 18.86 | 17.84 |
| P/OCF | 7.39 | 12.24 | 13.76 | 12.17 | 12.80 | 10.46 | 11.62 | 13.82 | 17.01 | 14.91 | 14.10 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
Amdocs Limited's enterprise value stands at 5.9x EBITDA, 49% below its 5-year average of 11.5x. The Technology sector median is 16.7x, placing the stock at a 65% discount on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 2.13 | 2.08 | 2.11 | 2.17 | 2.30 | 1.85 | 2.10 | 2.28 | 2.28 | 2.20 |
| EV / EBITDA | 5.93 | 9.49 | 12.67 | 12.12 | 11.17 | 12.21 | 9.71 | 11.08 | 14.17 | 12.06 | 11.77 |
| EV / EBIT | 7.33 | 13.22 | 16.63 | 15.62 | 14.94 | 11.80 | 12.97 | 15.03 | 21.36 | 17.17 | 16.81 |
| EV / FCF | — | 14.99 | 16.82 | 14.75 | 18.77 | 13.78 | 17.01 | 16.27 | 27.79 | 17.57 | 16.68 |
Margins and return-on-capital ratios measuring operating efficiency
Amdocs Limited earns an operating margin of 18.2%. Operating margins have expanded from 13.4% to 18.2% over the past 3 years, signaling improving operational efficiency. ROE of 16.2% indicates solid capital efficiency. ROIC of 15.6% represents solid returns on invested capital.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 36.6% | 36.6% | 35.1% | 35.3% | 35.4% | 34.5% | 33.9% | 35.1% | 34.7% | 35.2% | 35.2% |
| Operating Margin | 18.2% | 18.2% | 12.6% | 13.4% | 14.5% | 14.0% | 14.3% | 13.9% | 10.8% | 13.4% | 13.0% |
| Net Profit Margin | 12.5% | 12.5% | 9.9% | 11.1% | 12.0% | 16.1% | 11.9% | 11.7% | 8.9% | 11.3% | 11.0% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 16.2% | 16.2% | 14.0% | 15.2% | 15.3% | 18.9% | 13.8% | 13.6% | 10.0% | 12.4% | 11.9% |
| ROA | 8.9% | 8.9% | 7.7% | 8.4% | 8.5% | 10.7% | 8.6% | 9.0% | 6.7% | 8.2% | 7.7% |
| ROIC | 15.6% | 15.6% | 12.1% | 12.8% | 13.1% | 11.9% | 13.1% | 13.9% | 10.7% | 13.4% | 13.2% |
| ROCE | 16.8% | 16.8% | 12.6% | 12.8% | 12.9% | 11.6% | 12.9% | 14.0% | 10.5% | 12.8% | 12.2% |
Solvency and debt-coverage ratios — lower is generally safer
Amdocs Limited carries a Debt/EBITDA ratio of 0.8x, which is very conservative (72% below the sector average of 2.9x). Net debt stands at $501M ($826M total debt minus $325M cash). Interest coverage of 17.2x signals virtually no risk of debt distress — earnings comfortably cover interest obligations.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.24 | 0.24 | 0.23 | 0.23 | 0.23 | 0.24 | 0.28 | — | — | — | 0.06 |
| Debt / EBITDA | 0.81 | 0.81 | 0.96 | 0.95 | 0.93 | 1.09 | 1.30 | — | — | — | 0.29 |
| Net Debt / Equity | — | 0.14 | 0.13 | 0.08 | 0.07 | 0.05 | 0.01 | -0.13 | -0.12 | -0.18 | -0.16 |
| Net Debt / EBITDA | 0.49 | 0.49 | 0.54 | 0.34 | 0.28 | 0.21 | 0.06 | -0.61 | -0.65 | -0.89 | -0.82 |
| Debt / FCF | — | 0.78 | 0.72 | 0.41 | 0.48 | 0.24 | 0.11 | -0.89 | -1.28 | -1.29 | -1.16 |
| Interest Coverage | 17.24 | 17.24 | 17.94 | 28.56 | 39.34 | 39.28 | 56.94 | 146.20 | 153.51 | 321.57 | 291.76 |
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.17x means Amdocs Limited can comfortably meet its short-term obligations, though there is limited excess liquidity. The current ratio has declined from 1.41x to 1.17x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.17 | 1.17 | 1.20 | 1.41 | 1.60 | 1.59 | 1.71 | 1.39 | 1.33 | 1.75 | 1.54 |
| Quick Ratio | 1.17 | 1.17 | 1.20 | 1.41 | 1.60 | 1.59 | 1.71 | 1.39 | 1.33 | 1.75 | 1.54 |
| Cash Ratio | 0.24 | 0.24 | 0.35 | 0.55 | 0.65 | 0.74 | 0.81 | 0.39 | 0.40 | 0.84 | 0.80 |
| Asset Turnover | — | 0.73 | 0.78 | 0.76 | 0.72 | 0.66 | 0.66 | 0.77 | 0.74 | 0.73 | 0.70 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | 75.35 | 75.00 | 70.53 | 75.51 | 73.77 | 75.38 | 88.23 | 89.21 | 81.65 | 80.35 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Amdocs Limited returns 13.9% to shareholders annually — split between a 3.9% dividend yield and 10.0% buyback yield. The payout ratio of 39.7% is conservative, leaving significant room for dividend growth or reinvestment. The earnings yield of 9.8% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 3.9% | 2.4% | 2.1% | 2.0% | 1.9% | 1.8% | 2.1% | 1.6% | 1.4% | 1.3% | 1.2% |
| Payout Ratio | 39.7% | 39.7% | 43.0% | 36.9% | 33.9% | 25.8% | 33.0% | 30.8% | 37.9% | 27.8% | 26.7% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 9.8% | 6.2% | 4.9% | 5.3% | 5.6% | 7.0% | 6.5% | 5.2% | 3.7% | 4.6% | 4.7% |
| FCF Yield | 11.7% | 7.0% | 6.2% | 7.0% | 5.5% | 7.4% | 5.9% | 5.8% | 3.4% | 5.3% | 5.6% |
| Buyback Yield | 10.0% | 6.0% | 5.6% | 4.9% | 5.3% | 7.0% | 4.7% | 4.4% | 4.4% | 3.6% | 4.7% |
| Total Shareholder Yield | 13.9% | 8.5% | 7.8% | 6.9% | 7.2% | 8.9% | 6.9% | 6.0% | 5.8% | 4.9% | 6.0% |
| Shares Outstanding | — | $112M | $114M | $118M | $122M | $128M | $133M | $137M | $144M | $147M | $151M |
Compare DOX with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| $6B | 10.2 | 5.9 | 8.6 | 36.6% | 18.2% | 16.2% | 15.6% | 0.8 | |
| $2B | 40.8 | 7.3 | 16.3 | 47.5% | 24.5% | 19.7% | 32.5% | 1.6 | |
| $2B | -1.2 | 4.8 | 3.1 | 35.0% | 6.2% | -37.7% | 5.6% | 3.7 | |
| $4B | 11.4 | 4.4 | 6.5 | 26.5% | 9.6% | 10.3% | 15.5% | 0.2 | |
| $21B | 9.6 | 5.0 | 8.0 | 33.7% | 16.7% | 15.2% | 18.7% | 0.4 | |
| $25B | 18.1 | 13.4 | 15.4 | 30.7% | 17.0% | 16.8% | 13.4% | 1.1 | |
| $80B | 10.7 | 6.1 | 7.4 | 31.9% | 14.7% | 25.0% | 26.8% | 0.6 | |
| $234B | 22.3 | 18.7 | 20.2 | 59.5% | 15.3% | 35.2% | 9.8% | 4.4 | |
| $43B | 13.9 | 8.8 | 10.5 | 30.5% | 21.1% | 28.9% | 31.8% | 0.2 | |
| $1B | 13.4 | 4.7 | 5.1 | 35.0% | 7.0% | 4.9% | 5.5% | 1.4 | |
| $13B | 9.6 | 7.6 | 8.3 | 17.7% | 12.3% | 30.9% | 17.1% | 2.5 | |
| Technology Median | — | 29.0 | 16.7 | 19.2 | 48.8% | 0.2% | 1.6% | 2.7% | 2.9 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Includes 30+ ratios · 29 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying DOX stock.
Amdocs Limited's current P/E ratio is 10.2x. The historical average is 24.3x.
Amdocs Limited's current EV/EBITDA is 5.9x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 13.4x.
Amdocs Limited's return on equity (ROE) is 16.2%. The historical average is 20.9%.
Based on historical data, Amdocs Limited is trading at a P/E of 10.2x. Compare with industry peers and growth rates for a complete picture.
Amdocs Limited's current dividend yield is 3.90% with a payout ratio of 39.7%.
Amdocs Limited has 36.6% gross margin and 18.2% operating margin. Operating margin between 10-20% is typical for established companies.
Amdocs Limited's Debt/EBITDA ratio is 0.8x, indicating low leverage. A ratio below 2x is generally considered financially healthy.